Joint fluid interleukin-6 combined with the neutral polymorphonuclear leukocyte ratio (PMN%) as a diagnostic index for chronic periprosthesis infection after arthroplasty.
Xudong SuBo ZhuLeilei QinJianye YangLi WeiZhenghao XuKeyu WeiJiayi WangLi ChenChen ZhaoCheng ChenWei HuangYan XiongNing HuPublished in: Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology (2023)
Patients who underwent hip/knee revision at the First Hospital of Chongqing Medical University for periprosthetic infection or aseptic failure of the prosthesis after hip/knee arthroplasty from January 2018 to January 2020 were included. Trial registration This study was approved by the ethics committee of the First Hospital of Chongqing Medical University on September 26, 2018 (local ethics committee number: 20187101) and registered with the China Clinical Trials Registry (registration number: ChiCTR1800020440) with an approval date of December 29, 2018.
Keyphrases
- total hip arthroplasty
- healthcare
- clinical trial
- total knee arthroplasty
- end stage renal disease
- public health
- ejection fraction
- newly diagnosed
- big data
- chronic kidney disease
- phase ii
- total hip
- prognostic factors
- study protocol
- peritoneal dialysis
- randomized controlled trial
- drug administration
- knee osteoarthritis
- emergency department
- machine learning